Ophthalmology M&A Advisory
For multi-physician ophthalmology practices, integrated platforms with surgery center ownership, optical retail, and refractive services. PE consolidation in ophthalmology is well-established, with multiple large platforms competing for quality groups.
Speak with an advisor: (800) 815-0590How We Help Ophthalmology Sellers
Capital Partners' M&A framework is built around the specific dynamics of middle-market specialty practice transactions. The three engagement profiles below cover most of how ophthalmology practice owners come to us.
Four to twenty-five physician practices with established surgical volume, sub-specialty mix (cataract, retina, glaucoma, cornea, pediatric), and operational infrastructure. The institutional buyer market is well-developed for this segment.
Discuss your practice →Practices with affiliated ambulatory surgery centers, particularly those with significant cataract case volume, achieve meaningful valuation premiums. ASC ownership is a primary multiple expansion driver in ophthalmology.
Discuss your platform →Ophthalmology practices integrated with optical retail (eyewear, contact lenses) and refractive services achieve diversified revenue profiles attractive to institutional buyers. The recurring optical revenue adds meaningful value.
Discuss your group →Market Context
Ophthalmology has been an active consolidation category since the mid-2010s. Major PE-backed platforms including EyeSouth Partners, AEG Vision, Acuity Eye Group, US Eye, EyeCare Partners, and Florida Eye Care actively acquire practices. The platform landscape has matured to the point where multiple sophisticated buyers compete for quality middle-market groups.
The Capital Partners Approach
The ophthalmology platform landscape includes buyers with materially different cultures, governance models, and growth strategies. The right buyer for one practice may be wrong for another. Process discipline helps identify the right platform fit at the right terms, rather than accepting the first credible offer that arrives.
Ophthalmology practices considering institutional capital often benefit from a deliberate pre-process period of operational optimization — clean financials, articulated sub-specialty strategy, and clear physician compensation plans. The lift in valuation from preparation work typically far exceeds the cost.
Valuation Drivers
Ophthalmology practice valuation is driven by a specific set of operational, clinical, and structural factors. Below are the elements buyers evaluate most carefully when developing valuation and offer terms.
Surgery center ownership, particularly with significant cataract case volume, is a primary driver of multiple expansion. ASC EBITDA contribution is heavily valued.
Integrated optical retail (eyewear, contact lens, accessories) provides recurring high-margin revenue. Optical capture rates and per-patient revenue are evaluated.
Sub-specialty depth across cataract, retina, glaucoma, cornea, oculoplastics, and pediatric ophthalmology influences buyer evaluation. Sub-specialty diversity is generally valued.
LASIK, PRK, and other refractive procedures generate high-margin cash-pay revenue. Refractive surgery volume and pricing power factor into valuation.
Physician count, sub-specialty distribution, age/career stage, and post-close commitments all factor into buyer evaluation. Stability of the physician roster is critical.
Market position, referral network density, and competitive landscape in the metropolitan area influence valuation. Buyers prefer practices with demonstrated market share.
Begin a Conversation
The most useful next step is a confidential conversation. We'll listen to your situation, give you a directional view of where your practice sits in the current market, and explain how a Capital Partners engagement would actually run. Every conversation begins under NDA.
(800) 815-0590